Current state of the nanoscale delivery systems for temoporfin-based photodynamic therapy: Advanced delivery strategies
I Yakavets, M Millard, V Zorin, HP Lassalle… - Journal of controlled …, 2019 - Elsevier
Enthusiasm for photodynamic therapy (PDT) as a promising technique to eradicate various
cancers has increased exponentially in recent decades. The majority of clinically approved …
cancers has increased exponentially in recent decades. The majority of clinically approved …
In vitro and in vivo characterization of temoporfin-loaded PEGylated PLGA nanoparticles for use in photodynamic therapy
Aims: In this study we evaluated temoporfin-loaded polyethylene glycol (PEG) Poly-(d, l-
lactide-co-glycolide)(PLGA) nanoparticles (NPs) as a new formulation for potential use in …
lactide-co-glycolide)(PLGA) nanoparticles (NPs) as a new formulation for potential use in …
Photodynamic therapy with conventional and PEGylated liposomal formulations of mTHPC (temoporfin): comparison of treatment efficacy and distribution …
V Reshetov, HP Lassalle, A Francois… - International journal …, 2013 - Taylor & Francis
A major challenge in the application of a nanoparticle-based drug delivery system for
anticancer agents is the knowledge of the critical properties that influence their in vivo …
anticancer agents is the knowledge of the critical properties that influence their in vivo …
Clinical development of photodynamic agents and therapeutic applications
R Baskaran, J Lee, SG Yang - Biomaterials research, 2018 - spj.science.org
Background Photodynamic therapy (PDT) is photo-treatment of malignant or benign
diseases using photosensitizing agents, light, and oxygen which generates cytotoxic …
diseases using photosensitizing agents, light, and oxygen which generates cytotoxic …
[HTML][HTML] Current limitations and recent progress in nanomedicine for clinically available photodynamic therapy
Photodynamic therapy (PDT) using oxygen, light, and photosensitizers has been receiving
great attention, because it has potential for making up for the weakness of the existing …
great attention, because it has potential for making up for the weakness of the existing …
Advanced in silico modeling explains pharmacokinetics and biodistribution of temoporfin nanocrystals in humans
L Jablonka, M Ashtikar, G Gao, F Jung, M Thurn… - Journal of controlled …, 2019 - Elsevier
Foscan®, a formulation comprising temoporfin dissolved in a mixture of ethanol and
propylene glycol, has been approved in Europe for palliative photodynamic therapy of …
propylene glycol, has been approved in Europe for palliative photodynamic therapy of …
[HTML][HTML] Topical application of temoporfin-loaded invasomes for photodynamic therapy of subcutaneously implanted tumours in mice: a pilot study
N Dragicevic-Curic, S Gräfe, V Albrecht… - Journal of photochemistry …, 2008 - Elsevier
Temoporfin (mTHPC) represents a very potent second-generation synthetic photosensitizer.
It has shown to be effective in the photodynamic therapy of early or recurrent oral …
It has shown to be effective in the photodynamic therapy of early or recurrent oral …
Nanomaterials-based photosensitizers and delivery systems for photodynamic cancer therapy
XT Yu, SY Sui, YX He, CH Yu, Q Peng - Biomaterials Advances, 2022 - Elsevier
The increasing cancer morbidity and mortality requires the development of high-efficiency
and low-toxicity anticancer approaches. In recent years, photodynamic therapy (PDT) has …
and low-toxicity anticancer approaches. In recent years, photodynamic therapy (PDT) has …
Nanodrug applications in photodynamic therapy
Photodynamic therapy (PDT) has developed over last century and is now becoming a more
widely used medical tool having gained regulatory approval for the treatment of various …
widely used medical tool having gained regulatory approval for the treatment of various …
Nanoparticles in photodynamic therapy: an emerging paradigm
Photodynamic therapy (PDT) has emerged as one of the important therapeutic options in
management of cancer and other diseases [M. Triesscheijn, P. Baas, JH Schellens, FA …
management of cancer and other diseases [M. Triesscheijn, P. Baas, JH Schellens, FA …